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Abstract 
A 52-year-old woman presented with a large partially yellow and erythematous tumor on her 
right temple. She reported that it had grown over the last 4 years. Regional lymph nodes 
were impalpable. A punch biopsy showed eosinophilic material in the dermis and subcutis. 
Immunohistochemistry showed positive staining for kappa and lambda light chains. Electron 
microscopy showed the typical amyloid fibrils (7–10 nm in diameter). There was no evidence 
of systemic amyloidosis, paraproteinemia or underlying plasmacytoma. The tumor was com-
pletely removed via curettage. At follow-up, the patient presented in good health with no 
signs of relapse. © 2016 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Amyloidoses originate from the extracellular aggregation of autologous protein fibrils. 
Within these aggregations, the pentagonal amyloid P component serves as a stabilizer mole-
cule. Amyloidoses can be classified into three categories: primary localized cutaneous amy-
loidosis (PLCA), secondary localized cutaneous amyloidosis, and systemic amyloidosis with 
cutaneous involvement [1]. In the PLCA group, three types can be distinguished: macular, 
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papular (lichenoid) and nodular forms [1–4]. The first two are mainly located on the trunk, 
and cytokeratins serve as the amyloid precursors. Here, amyloid deposition is limited to the 
papillary dermis [1–5]. However, in the rare cases of nodular PLCA, amyloid consists of ag-
gregated kappa and lambda light chains, which can be found both in the dermis and the sub-
cutaneous tissue [1–4, 6]. Furthermore, nodular PLCA can originate from systemic amyloi-
dosis or progress to systemic disease [3, 4]. Here, we present a case of nodular PLCA on the 
temple of a 52-year-old woman. 
Case Report 
A 52-year-old lady presented with a soft, shiny, partially yellow, erythematous tumor 
(3.5 × 4.5 cm) with telangiectasia on her right temple (fig. 1a, b). She recalled having had this 
tumor for about 4 years and that it had significantly grown lately. She negated pruritus.  
Regional lymph nodes were impalpable. A punch biopsy showed amorphous eosinophilic 
material within the dermis and subcutis (fig. 1c, d) which was positive in Congo red staining. 
In immunohistochemistry, the stainings for kappa and lambda light chains were positive  
(fig. 1e, f). The diagnosis was confirmed by electron microscopy, and the typical amyloid 
fibrils (7–10 nm in diameter) were found (fig. 1g, h) [3]. The tumor was completely removed 
via curettage. Additionally, a punch biopsy from abdominal fat tissue was examined via elec-
tron microscopy [7]. There was no evidence of systemic amyloidosis. An electrocardiogram 
and abdominal sonography showed no pathologies. There were no signs of paraproteinemia 
or underlying plasmacytoma. Therefore, the diagnosis was nodular PLCA. A punch biopsy 
taken during follow-up showed some remaining amyloid so that the patient is now sched-
uled to undergo a second surgery via curettage. Regular check-ups are scheduled to detect a 
potential progress to systemic disease. 
Discussion 
The diagnosis of PLCA requires histological analysis of a skin specimen, complemented 
by immunohistochemistry and electron microscopy. Histologically, eosinophilia as well as 
positivity in periodic acid-Schiff, Congo red, and thioflavin T stainings are characteristics of 
amyloid deposits [1, 8]. Immunohistochemistry with antibodies directed against cytokeratin 
and immunoglobulin light chains (lambda and kappa) allows to further distinguish between 
the different forms of PLCA. Electron microscopy confirms the diagnosis of amyloidosis 
when the typical amyloid fibrils (7–10 nm in diameter) are found. Image quality improves 
significantly when the skin sample is fixed in Karnofsky’s fixative (glutaraldehyde) instead  
of paraformaldehyde [4]. For patients with nodular PLCA, it is recommended to asses for 
progression to systemic amyloidosis on a regular basis. This should include a full history and 
physical examination along with electrocardiogram, complete blood count, serum creatinine 
levels, serum liver-associated enzyme levels, serum electrophoresis, and urine examination 
[1]. Progression to systemic disease has been described to occur in 5–50% of cases [1]. Fur-
thermore, an abdominal fat biopsy has been suggested as an easy method to detect a poten-
tial progression to systemic disease [3, 7]. Nodular PLCA is extremely rare, accounting for 
around 1.5% of PLCA cases [1]. It has to be mentioned though that nodular PLCA is more 
frequent in Asia and South America when compared to Europe or North America. 
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Fig. 1. a, b Large tumor on the right temple of a 52-year-old woman. The sharply demarcated tumor exhib-
ited a shiny, yellow-reddish surface with some telangiectasias. c, d A punch biopsy showed amorphous 
eosinophilic material in the dermis and subcutis. e, f Immunohistochemistry revealed massive amounts of 
both kappa and lambda immunoglobulin light chains. g, h Under electron microscopy, the typical amyloid 
fibrils (7–10 nm in diameter) were seen. 
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